Re¯exive erection initiated by recruitment of penile afferents, involves both autonomic and somatic efferents. The re¯ex is mediated at the spinal cord level, modulated by supraspinal in¯uences, and may use several transmitters. Dopamine, acetylcholine, nitric oxide, and peptides, such as oxytocin and ACTHaa-MSH, seem to have a facilitatory role, whereas serotonin may be either facilitatory or inhibitory, and enkephalins are inhibitory. Peripherally, the balance between contractant and relaxant factors controls the degree of contraction of the smooth muscle of the corpora cavernosa, and determines the functional state of the penis. Noradrenaline contracts both corpus cavernosum and penile vessels via stimulation of a 1 -adrenoceptors. The role of endothelins in the control of penile smooth muscle tone is presently unclear. Neurogenic nitric oxide (NO) is considered the most important factor for relaxation of penile vessels and corpus cavernosum. The role of other mediators, released from nerves or endothelium has not been de®nitely established.
Introduction
The central regulation of erection with processing and integration of tactile, olfactory, auditory and mental stimuli, involves many transmitters and transmitter systems. This is also the case peripherally, and the different steps involved in neurotransmission, impulse propagation and intracellular transduction of neural signals in penile smooth muscles are only partly known. Re¯exive erection initiated by recruitment of penile afferents involves both autonomic and somatic efferents. The re¯ex is mediated at the spinal cord level and modulated by supraspinal in¯uences, and involves several transmitters. 1 ± 6 Peripherally, the balance between contractant and relaxant factors controls the degree of contraction of the smooth muscle of the corpora cavernosa, and determines the functional state of the penis: detumescence and¯accidity, and tumescence and erection, respectively. 6, 7 Below a short review is given of some of the transmittersamodulators believed to be involved in the control of erectile mechanisms centrally and peripherally.
Central neuromediation
The central mechanisms in¯uencing the erectile response include spinal and supraspinal pathways. Several regions within the central nervous system may be involved. 2 Much of the knowledge gained in this area relates to morphological and pharmacological studies in experimental animal models (eg rodents, primates) in which neurochemical perturbations can be achieved and responses monitored in a reasonably meaningful way. For example, studies in rats have revealed that electrical stimulation of the medial preoptic area, 8 the paraventricular nucleus, 9 or the hippocampal formation 10 elicits an erectile response.
Hydroxytryptamine 5-hydroxytryptamine (5-HT; serotonin) is present in supraspinal as well as spinal and peripheral sites believed to be involved in sexual behavior. Neurons containing 5-HT can be found in the medullary raphe nuclei and ventral medulla reticular formation, including the rostral nucleus paragigantocellularis. Bulbospinal neurons containing 5-HT project to the lumbar spinal cord in the rat and cat. 2 Fibres immunoreactive for serotonin were largely and densely distributed in the dorsal horn, the dorsal gray commissure, the sacral parasympathetic nucleus and the ventral horn. Some serotonergic ®bres occurred in close apposition with retrogradelylabelled sacral preganglionic neurons and motor neurons and synapses were demonstrated at the ultrastructural level. 11 5-HT has been most strongly implicated in the spinal pharmacology of erectile function with participation in both sympathetic and parasympathetic out¯ow mechanisms. Experimental paradigms in animals have indicated that 5-HT pathways exert a general inhibitory effect on male sexual behavior, 12 although these pathways may be inhibitory or facilitatory depending upon the action of the amine at different 5-HT receptors located in the central nervous system. 1, 13 Despite this general understanding, con¯icting reports of 5-HT agonists either enhancing or depressing sexual function were recognized and then attributed to the action of multiple 5-HT receptors.
In accordance with the selective use of 5-HT receptor agonists and antagonists, components of male copulatory behavior were found to be displayed variably. The sum of multiple studies suggests that 5-HT 2 and 5-HT 1A receptors mediate inhibitory effects on penile erection, whereas 5-HT 1C receptors mediate facilitatory effects on this function. 14 Stimulation of 5-HT 1C receptors increased circulating oxytocin, 15 and nitric oxide synthase (NOS) inhibitors given by intracerebrovascular administration prevented 5-HT 1C -receptor mediated erectile responses, 16 suggesting that both oxytocin and NO were involved in the 5-HT 1C -receptor mediated responses.
Thus, 5-HT appears to serve various functions in male sexual function and likely acts as a major modulator of the central neuroregulatory control of penile erection.
Dopamine
Dopaminergic neurons have been identi®ed as traveling from the caudal hypothalamus to innervate the lumbosacral spinal cord and dopamine may participate in the CNS regulation of the autonomic and somatic components that produce penile re¯exes. Supraspinal dopaminergic neurons also comprise the incertohypothalamic system with projections to the medial preoptic area and paraventricular nucleus. Injection of apomorphine into these central nuclei has facilitatory effects on sexual behavior, 2, 17 and produces the`penile erectionstretching-yawning' response.
Two main types of dopamine receptors, D1 and D2, are associated with erectile function centrally, with the latter perceived to predominate in this effect. In the medial preoptic area, use of selective receptor agonists has established that low levels of dopaminergic stimulation, via D1 receptor in particular, facilitates erections. 18, 19 In the paraventricular nucleus, similar experiments have established that D2 rather than D1 receptors primarily facilitate erections. 17 The mechanism of erection following paraventricular D2 receptor stimulation apparently involves oxytocinergic neurotransmission. In addition, NO seems to be involved, since apomorphine (given s.c.) increased NOS activity and NO production in the paraventricular nucleus. 20 Both the increase in NO and the erectile response to apomorphine were reduced by NOS inhibition.
Noradrenaline
Evidence for noradrenergic effects in the central neuromediation of penile erection is sparse. However, the current data suggest that increased nor-adrenergic activity stimulates, whereas decreased noradrenergic activity inhibits, sexual function. 12, 21, 22 Gamma-amino butyric acid Cumulative data resulting from investigations on the role of gamma-aminobutyric acid (GABA) in penile erection indicate that this neurotransmitter may function as an inhibitory modulator in the autonomic and somatic re¯ex pathways involved in penile erection. 1 Recent investigations showed that activation of GABA(A) receptors in the paraventricular nucleus of the hypothalamus reduced apomorphine-, N-methyl-D-aspartic acid (NMDA-), and oxytocin-induced penile erection and yawning in male rats. 23 
Oxytocin
Hypothalamic supraoptic and paraventricular nuclei project to spinal centers in¯uencing erectile function. 2 The oxytocinergic spinal projections are more likely to in¯uence sacral autonomic rather than somatic out¯ow. 24 Plasma oxytocin concentrations are known to be elevated in humans following sexual stimulation.
When injected into the lateral cerebral ventricle, the paraventricular nucleus, or hippocampus of laboratory animals, oxytocin is a potent inducer of penile erection. Oxytocin receptors are believed to mediate the erections, since the erectile response is blocked by the administration of oxytocin antagonists and by electrolytic lesion of the paraventricular nucleus. Immunoreactive oxytocin-containing spinal neurons associating with sacral preganglionic neurons con®rmed by retrograde labelling supports the role of oxytocin in the autonomic spinal circuitry that mediates penile erection. 11, 25 Central oxytocin seems to be involved in the expression of penile erection induced not only by drugs but also by sexual physiological stimuli, since non-contact erections in rats were reduced dosedependently by a selective oxytocin receptor antagonist, given into the lateral ventricles. 26 The oxytocinergic system may be in¯uenced by the NO synthase signal transduction pathway, since inhibitors of this pathway prevent penile erection and yawning in rats induced by oxytocin, dopamine, and NMDA stimulation. Conversely, oxytocin increases NO production in the paraventricular nucleus. 27 
ACTH and related peptides
Peptides derived from the common 31 kDa precursor pro-opiomelanocortin, including adrenocorticotropic hormone (ACTH) and a-melanocyte stimulating hormone (a-MSH), have been associated with erectile responses. Both peptides can induce penile erection along with grooming, stretching and yawning following its intracerebroventricular injection. 28 In humans, an a-MSH analogue, melanotan II, was reported to initiate erection in men with psychogenic erectile dysfunction. 29 ACTH and a-MSH act on melanocortin receptors, and the cloning of ®ve different subtypes of melanocortin receptor has recently opened up new possibilities for the development of drugs. 30 Argiolas et al showed that the peptides act in the hypothalamic periventricular region, and that grooming, stretching and yawning, but not penile erection, are mediated by melanocortin-4 receptors. 28 
Opioid peptides
Endogenous opioid peptides have long been assumed to be involved in the regulation of male sexual responses, since sexual dysfunction has been observed clinically in men chronically using opiates, and copulatory behavior in male rats can be experimentally depressed with the systemic administration of morphine or other opioids. Current data support the hypothesis that opioid m receptor stimulation centrally prevents penile erection by inhibiting mechanisms that converge upon central oxytocinergic neurotransmission of this function. 2 Morphine injected into the paraventricular nucleus of the hypothalamus of rats prevented noncontact penile erections and impaired copulation. These effects of morphine are apparently mediated by a prevention of the increased nitric oxide production that occurs in the paraventricular nucleus during sexual activity. 31 Morphine also prevents apomorphine-, oxytocin-and NMDA-induced penile erection and yawning by inhibiting NO synthase activity in the paraventricular nucleus through the stimulation of opioid receptors of the m subtype. 32, 33 Nitric oxide
Evidence is accumulating that NO functions as a neurotransmitter in the CNS, where NO can modulate sexual behavior and penile erection. 16,34 ± 37 NO may act in several discrete brain regions, eg in the medial preoptic area 36, 37 as well as in the paraventricular nucleus. 9, 16 Injection of NOS inhibitors intracerebroventricularly or in the paraventricular nucleus prevented penile erectile responses induced by dopamine agonists, oxytocin, and NMDA in rats. The inhibitory effect of NOS inhibitors was not observed when these compounds were injected concomitantly with L-arginine, the substrate for NO. 16 NO production increased in the paraventricular nucleus of the hypothalamus of male rats during non-contact penile erections and copulation, con®rming that nitric oxide is a physiological mediator of penile erection at the level of the paraventricular nucleus. 35 NO may mediate the actions of ACTH and 5-HT 1C agonists which elicit erections when injected into the intracerebroventricular system according to mechanisms unrelated to oxytocinergic neurotransmission. 16 
Peripheral neuromediation
The different structures of the penis receive sympathetic, parasympathetic, somatic, and sensory innervation. 2, 38 The distribution of autonomic nerves within the corpora cavernosa has been studied by several investigators, but the density of nerves and the quantitative relations between the number of nerve terminals and and the number of smooth muscle cells have not been established. The nerves contain different transmitters, and the nerve populations have been categorized as adrenergic, cholinergic, and non-adrenergic, non-cholinergic (NANC). The latter nerves may contain not only neuropeptides, but also transmitters and transmitteramodulator generating enzymes, such as NOS (NOS) and heme oxygenases (HO). Thus, it seems that one important population of nerves in the corpora cavernosa contain not only acetylcholine, but also NOS, vasoactive intestinal polypeptide (VIP), and neuropeptide Y. 39, 40 The nerves and vasculature of the penis produce and release transmitters and modulators, producing contraction or relaxation. These transmittersa modulators interact in their control of the contractile state of the corpus cavernosum smooth muscle. In addition they may also have other important functions, some of which are discussed later.
Contraction-mediating transmitters and receptors
Noradrenaline and a-adrenoceptors: Penile arteries, cavernosal smooth muscle, and the principal penile veins receive adrenergic innervation, 41 and it is generally accepted that the penis is kept in thē accid state mainly via a tonic activity in these nerves through release of NA. Noradrenaline stimulates a-adrenoceptors (ARs) in the penile vasculature contracting the helicine vessels, and in the corpus cavernosum, contracting the trabecular smooth muscle. 2 Noradrenaline stimulates not only a-, but also b-ARs. However, in the human corpus cavernosum, receptor binding studies have revealed that the density of a-ARs is almost 10 times higher than that of b-ARs. It is not only the number of receptors that is of importance. Androgens may regulate the a-AR responsiveness of cavernous smooth muscle. Compared to normal rats, castrated animals showed an enhanced reactivity to a 1 -AR stimulation. 42 Both a 1 -and a 2 -ARs have been demonstrated in human corpus cavernosum tissue, but available information supports the view of a functional predominance of a 1 -ARs. This may also be the case in the penile vasculature, although a contribution of a 2 -ARs to the contraction induced by NA and electrical stimulation of nerves cannot be excluded. 2 An important question is whether or not one of the a 1 -AR subtypes is more important than the others for the contractile effects of NA. The subtypes of a 1 -AR with high af®nity for prazosin, currently designated as a 1A , a 1B , and a D have been demonstrated in human corporal tissue. In human corporal tissue, mRNAs for a 1A , a 1B , and, a 1D have been identi®ed, the a 1A -and a 1D -ARs predominating. However, at the protein level, only a 1A -and a 1B -ARs were expressed. 43 On the other hand, functional studies of human corpus cavernosum tissue, using receptor binding and isometric tension experiments showed the presence of a 1A -, a 1B -, and a 1D -ARs, and the NA-induced contraction in this tissue was suggested to be mediated by two or possibly all of the receptor subtypes. 41 An additional a 1 -AR subtype with low af®nity for prazosin (a 1L ), which is not yet fully characterized, may occur in, for example, vascular smooth muscle. The possibility that the a 1L -AR subtype may be of importance in human penile erectile tissues was recently suggested. 44 In rats, a 1B -, and a 1L -AR subtypes seem functionally relevant for erectile function, and a 1B -, andaor a 1L -AR subtype selective antagonists were suggested to represent advantages in the treatment of erectile dysfunction. 45 This may be correct. However, the distribution of a 1 -AR subtypes in the penis and systemic vasculature may not be the same in rats and humans, and the method of study may in¯uence the results. For example, Hussain and Marshall found in vitro that the a 1D -AR predominated in several systemic rat vessels, 46 which may not be the case in humans. 47 Tong and Cheng found a 1A -ARs to be responsible for the contractile response of rat corpus cavernosum, which does not seem to be in agreement with the in vivo data. 48 Expression of mRNA for a 2A -, a 2B -, and a 2C -ARs in whole human corpus cavernosum tissue has been demonstrated, a 2A -ARs predominating. 43 Radioligand binding studies with a highly selective ligand for a 2 -ARs revealed speci®c a 2 -AR binding sites, and functional experiments showed that the selective a 2 -AR agonist, UK 14,304, induced concentrationdependent contractions of isolated strips of human corpus cavernosum smooth muscle. 49 Whether or not these a 2 -ARs are of importance for the contractile regulation of tone in corpus cavernosum smooth muscle is still unclear. Prejunctional a 2 -ARs have been shown to modulate stimulus-evoked release of NA from nerves in the human corpus cavernosum, stimulation inhibiting the release of the amine. However, stimulation of prejunctional a 2 -ARs in horse penile resistance arteries was shown also to inhibit NANC-transmitter release. 50 This might be one of the mechanisms by which NA maintains detumescence.
Endothelins and endothelin receptors: Endothelins (ETs) have been demonstrated in penile erectile tissues and it is suggested that they contribute to the maintenance of corporal smooth muscle tone. 2 Cultured endothelial cells from the human corpus cavernosum, but not non-endothelial cells, expressed ET-1 mRNA. In the endothelium of human cavernous tissue, intense ET-like immunoreactivity was observed; immunoreactivity was also observed in the cavernous smooth muscle. Binding sites for ET-1 were demonstrated by autoradiography in the vasculature and cavernous tissue. Both ET A and ET B receptors have been found in human corporal smooth muscle membranes, and it cannot be excluded that both receptor subtypes are functional.
ET-1 potently induces slowly developing, longlasting contractions in different penile smooth muscles: corpus cavernosum, cavernous artery, deep dorsal vein, and penile circum¯ex veins. 2 Contractions can be evoked in human corpus cavernosus tissue also by ET-2 and ET-3, although these peptides have a lower potency than ET-1. 51 The contractions induced by ET-1 may be dependent on both transmembrane calcium¯ux (through voltage-dependent andaor receptor-operated calcium channels) and on the mobilization of inositol trisphosphate-(IP 3 -) sensitive intracellular calcium stores. ET-1 may function not only as a long-term regulator of corporal smooth muscle tone, but also as modulator of the contractile effect of other agents, eg NA, or as a modulator of cellular proliferation and phenotypic expression.
Even if much of the in vitro information available suggests that ETs may be of importance for erectile physiology and pathophysiology, the role of the peptides in vivo is unclear.
Relaxation-mediating transmitters and receptors
Acetylcholine and cholinergic receptors: The importance of parasympathetic nerves for producing penile erection has been well established. 2 Penile tissues from humans and several animal species are rich in nerves staining for acetylcholine (ACh) esterase. 38 From these nerves, ACh can be released by transmural electrical ®eld stimulation. In isolated corpus cavernosum cells, carbachol consistently produced contraction. This means that relaxation induced by ACh can be obtained either by inhibition of the release of a contractant factor, eg NA, andaor is produced by the release of a relaxation-producing factor, eg NO.
It is important to stress that parasympathetic activity is not equivalent with the actions of ACh; other transmitters may be released from cholinergic nerves. 39, 40 Parasympathetic activity may produce penile tumescence and erection by inhibiting the release of NA through stimulation of muscarinic receptors on adrenergic nerve terminals, andaor by releasing NO and, eg vasodilating peptides from nerves and endothelium.
Nitric oxide and the guanylate cyclaseacGMP pathway: An important role for NO in the relaxation of corpus cavernosum smooth muscle and vasculature is widely accepted. 2, 52 In vitro, several investigators have shown that both acetylcholineand neuronally mediated relaxation in animal and human corpus cavernosum involves release of NO, or a NO-like substance. 2 Both the endothelium andaor the nerves innervating the corpus cavernosum may be the source of the NO, and thus, more than one isoform of NOS can be involved.
Mice lacking nNOS have erections, show normal mating behaviour, and respond with erection to electrical stimulation of the cavernous nerves. 53 Surprisingly, isolated corporal tissue from both wild type and nNOS-deleted animals showed similar responses to electrical stimulation. It was suggested that eNOS is essential for erection, not only in nNOS deleted, but also in normal mice. eNOS is expressed in cavernosal smooth muscle and could be a main source of NO alongside nNOS. However, it was shown that mice carrying a mutation in the nNOS gene are still able to express an alternatively spliced mRNA of nNOS, which could be the source of NO in nNOS mutant mice. 54 Since NO is produced, and the guanylylacGMPacGKI pathway apparently is intact in the corpus cavernosum of these animals, they are not suitable to test whether or not this pathway is a prerequisite for normal penile erection.
cGMP signals via three different receptors in eukaryotic cells, including ion channels, phosphodiesterases, and protein kinases. At present, however, the molecular targets which are activated by cGMP and ®nally execute the relaxation of penile smooth muscle are not known. Two different cGMPdependent protein kinases (cGK I and II) have been identi®ed in mammals. Inactivation of cGKI in mice abolished both NOacGMP-dependent relaxation of vascular and intestinal smooth muscle and inhibition of platelet aggregation, causing hypertension, intestinal dysmotility and abnormal hemostasis. 55 cGKI-de®cient mice show a very low ability to reproduce. Corpus cavernosum tissue from these mice has an inability or markedly reduced ability to relax in response to neuronally or endothelially released, or exogenously administered NO. 56 Analysis of the NOacGMP-induced relaxation clearly showed that cGKI is the major mediator of the cGMP signaling cascade in mouse corpus cavernosum tissue. Its absence cannot be compensated by the cAMP signaling cascade that relaxes normal and cGKI-null penile erectile tissue to a similar extent. Taken together, these ®ndings suggest that activation of cGKI is a key step in the signal cascade leading to penile erection.
Vasoactive intestinal polypeptide (VIP) and VIP receptors: The penis of humans as well as animals is richly supplied with nerves containing VIP. 38 The majority of these nerves also contain immunoreactivity to NOS, and colocalization of NOS and VIP within nerves innervating the penis of both animals and humans has been demonstrated by many investigators. It seems that most of these NO-and VIP-containing neurons are cholinergic, since they also contain VAChT, 39 which is a speci®c marker for cholinergic neurons. VIP receptors (types 1 and 2), linked via a stimulatory G-protein to adenylyl cyclase, are considered to mediate the actions of the peptide. 57 The importance of the different subtypes of VIP in penile tissues have not been clari®ed. VIP related peptides, eg pituitary adenylyl cyclase-activating peptide (PACAP), which has been found to be colocalized with VIP in penile nerves, seem to act through one of the VIP receptors. The stimulatory effect of VIP on adenylyl cyclase leads to an increase in cAMP, which in turn activates cAMP-dependent protein kinase.
Undeniably, VIP has an inhibitory and relaxationproducing effect on strips of human corpus cavernosum tissue and cavernosal vessels in vitro, but it has been dif®cult to convincingly show that VIP released from nerves is responsible for relaxation of penile smooth muscle in vitro or in vivo. 2, 58 Whether or not VIP has a role as a neurotransmitter or modulator of neurotransmission in the penis has not been established. Even if its physiological role in penile erection and in erectile dysfunction remains to be settled, VIP receptors in the penis are an interesting therapeutic target.
Prostanoids and prostanoid receptors: Prostaglandins (PGs) and thromboxanes are locally acting hormones derived from arachidonic acid by the action of cyclooxygenases. Human corpus cavernosum tissue has the ability to synthetize various prostanoids, and also has the ability to locally metabolize them. 2 The production of prostanoids can be modulated by oxygen tension and suppressed by hypoxia. There are ®ve primary active prostanoid metabolites: PGD 2 , PGE 2 , PGF 2 , PGI 2 , and TXA 2 , and it has been proposed that there are ®ve major groups of receptors, corresponding to these metabolites, that mediate their effects, namely DP, EP, FP, IP, and TP receptors. cDNAs encoding representatives of each of these groups of receptors have been cloned, including several subtypes of EP receptors. The prostanoid receptors are G-protein-coupled receptors with differing transduction systems.
Penile tissues may contain most of these groups of receptors. However, their role in penile physiology is still far from established. Prostanoids may be involved in contraction of erectile tissues via PGF 2a and thromboxane A 2 , stimulating TX and FP receptors and initiating phosphoinositide turnover, as well as in relaxation via PGE 1 and PGE 2 , stimulating EP receptors (EP2aEP4) and initiating an increase in the intracellular concentration of cAMP. Prostanoids may also be involved in inhibition of platelet aggregation and white cell adhesion, and recent data suggest that prostanoids and transforming growth factor-b 1 (TGF-b 1 ) may have a role in modulation of collagen synthesis and in the regulation of ®brosis of the corpus cavernosum. 59 
Conclusions
The central regulation of the erectile process involves several transmitters, including dopamine, serotonin, noradrenaline, nitric oxide, and peptides, such as oxytocin and ACTHaa-MSH, but is still only partly known. Peripherally, the different steps involved in neurotransmission, impulse propagation and intracellular transduction of neural signals in penile smooth muscles also need further investigation. This work was supported by grants from the Swedish Medical Research Council (grant no 6837), and the Medical Faculty, University of Lund, Sweden.
